Remus Pharmaceuticals Limited is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). Remus Pharmaceuticals also provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
Remus Pharmaceuticals has its presence through registered and/or under registration products in countries namely Bhutan, Bolivia, Chile, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, Vietnam.
The company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.
As on 31 January 2023, Companies product portfolio consists of 429 products. The company operate under different brand names across the
globe.
As on January 31, 2023, we have business to business supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply.
Remus Pharmaceuticals IPO – Details
| IPO Opening Date | 17 May 2023 |
| IPO Closing Date | 19 May 2023 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 3,88,000 Shares Worth ₹47.69 Crore Fresh Issue: 33,20,000 Shares Worth ₹47.69 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹1150 – ₹1229 |
| Market Lot | 100 Shares |
| Min Order | 100 Shares (1 Lot) |
| Listing At | NSE SME |
| Register | Link Intime India Private Limited |
| QIB Shares Offered | 50% |
| Retail Shares Offered | 35% |
| NII (HNI) Shares Offered | 15% |
Remus Pharmaceuticals IPO – Date Schedule
| IPO Open Date | 17 May 2023 |
| IPO Close Date | 19 May 2023 |
| Basis of Allotment | 24 May 2023 |
| Initiation of Refund | 25 May 2023 |
| Credit of Shares to Demat Account | 26 May 2023 |
| IPO Listing Date | 29 May 2023 |
Remus Pharmaceuticals IPO– Lots Size & Price
| Application | Lots | Shares | Amount ( Cut-Off) |
| Retail (Minimum) | 1 | 100 | 1,22,900 |
| Retail (Maximum) | 1 | 100 | 1,22,900 |
| HNI (Minimum) | 2 | 200 | 2,45,800 |
Competitive Strengths
- Experienced Promoters and Management Team.
- Wide range of Products.
- Strategic Location of Contract Manufacturing Facilities.
- Diversified business operations and revenue base.
- Scalable Business Model.
Company Promoters
- Mr. Arpit Deepakkumar Shah
- Ms. Roma Vinodbhai Shah
- Mr. Swapnil Jatinbhai Shah
- Mrs. Anar Swapnil Shah
Object Of The Issue
- To Meet Working Capital Requirements.
- Funding investments for acquisitions and general corporate purposes.
- To meet Public Issue Expenses.
Company Financial
| Particulars | Total Revenue | Total Expense | Profit After Tax |
|---|---|---|---|
| 31 March 2020 | 12.76 | 11.67 | 0.81 |
| 31 March 2021 | 19.22 | 17.86 | 1.02 |
| 31 March 2022 | 25.43 | 20.88 | 3.38 |
| 31 December 2022 | 33.61 | 24.91 | 6.43 |
Remus Pharmaceuticals IPO Promoter Holding
| Pre Issue Share Holding | 92.16% |
| Post Issue Share Holding | 67.88% |
Remus Pharmaceuticals IPO Prospectus
Company Contact Information
| Remus Pharmaceuticals Limited 1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ambli bopal Road, Ahmedabad – 380054, Gujarat, India Phone: +079- 2999 9857 Email: cs@remuspharma.com Website: www.remuspharma.com |
Remus Pharmaceuticals IPO Registrar
| Link Intime India Private Limited Phone: +91 810 811 4949 Email: remuspharmaceuticals.ipo@linkintime.co.in Website: www.linkintime.co.in |
Remus Pharmaceuticals IPO Lead Manager(s)
| 1. Beeline Capital Advisors Private Limited |
Remus Pharmaceuticals IPO FAQs
| What is Remus Pharmaceuticals IPO? Remus Pharmaceuticals IPO is a SME IPO. The issue is priced at ₹1150 – ₹1229 per equity share. The IPO is to be listed on NSE SME. |
| When Remus Pharmaceuticals IPO will open? The IPO is to open on 17 May 2023 for QIB, NII and Retail Investors. |
| What is Remus Pharmaceuticals IPO Investors Portion? The investors portion for QIB-50%, NII-15%, and Retail-35%. |
| How to Remus Pharmaceuticals IPO? You can apply Remus Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Remus Pharmaceuticals IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Remus Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Remus Pharmaceuticals IPO through Edelweiss? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Remus Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Edelweiss. |
| What is Remus Pharmaceuticals IPO Size? Remus Pharmaceuticals IPO size is ₹47.69 crores. |
| What is Remus Pharmaceuticals IPO Price Band? Remus Pharmaceuticals IPO Price Band is ₹1150-₹1229. |
| What is Remus Pharmaceuticals IPO Minimum and Maximum Lot Size? The minimum bid is 100 Shares with ₹1,22,900 amount while the maximum bid is 100 shares with ₹1,22,900. |
| What is the Remus Pharmaceuticals IPO Allotment Date? Remus Pharmaceuticals IPO allotment date is 24 May 2023. |
| What is the Remus Pharmaceuticals IPO Listing Date? Remus Pharmaceuticals IPO listing date is 29 May 2023. The IPO is to list on NSE SME. |
